S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Adar1 Capital Management/Q2 2026

Adar1 Capital Management

Period: Q2 2026 · Filed: 2026-08-14
View on SEC EDGAR
AUM
$2.19B
Total portfolio value
Positions
277
Reported securities
Top Holding
ABVX
11.0% $240.5M
QoQ Changes
+8 / -8
new · exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings — not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares — not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with ≥$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-08-14) shown is the underlying stock price movement — not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ABVXABIVAX SA$240.5M11.01%$133.26$118.96-10.7%
11.0%
PTGXPROTAGONIST THERAPEUTICS INC$117.8M5.39%$122.58$155.10+26.5%
5.4%
ROIVROIVANT SCIENCES LTD$111.7M5.11%$35.39$36.20+2.3%
5.1%
SPYSTATE STR SPDR S&P 500 ETF T$96.4M4.41%$746.77$776.34+4.0%
4.4%
IMVTIMMUNOVANT INC$89.8M4.11%$38.53$41.82+8.5%
4.1%
ZLABZAI LAB LTD$64.0M2.93%$19.00$25.90+36.3%
2.9%
AGIOAGIOS PHARMACEUTICALS INC$47.8M2.19%$37.11$33.56-9.6%
2.2%
CRNXCRINETICS PHARMACEUTICALS IN$45.7M2.09%$37.42$84.70+126.3%
2.1%
BOXXEA SERIES TRUST$39.5M1.81%$117.09$117.87+0.7%
1.8%
CYTKCYTOKINETICS INC$39.0M1.79%$85.19$74.13-13.0%
1.8%
SEPNSEPTERNA INC$31.5M1.44%$33.49$44.50+32.9%
1.4%
AVRANTERIS TECHNOLOGIES GLOBAL$31.0M1.42%$9.85$9.40-4.6%
1.4%
EDITEDITAS MEDICINE INC$28.8M1.32%$3.24$2.82-13.0%
1.3%
DNLIDENALI THERAPEUTICS INC$26.5M1.21%$25.72$24.40-5.1%
1.2%
SYRESPYRE THERAPEUTICS INC$25.2M1.15%$88.78$103.63+16.7%
1.1%
VIRVIR BIOTECHNOLOGY INC$25.0M1.15%$10.19$9.24-9.3%
1.1%
PRAXPRAXIS PRECISION MEDICINES I$24.9M1.14%$334.79$366.81+9.6%
1.1%
INSMINSMED INC$24.4M1.12%$106.62$123.74+16.1%
1.1%
CLDXCELLDEX THERAPEUTICS INC NEW$23.1M1.05%$37.21$41.95+12.7%
1.1%
VKTXVIKING THERAPEUTICS INC$22.4M1.02%$39.01$33.19-14.9%
1.0%
TSHATAYSHA GENE THERAPIES INC$20.7M0.95%$6.81$5.95-12.6%
0.9%
MNPRMONOPAR THERAPEUTICS INC$20.1M0.92%$92.59$113.04+22.1%
0.9%
OVIDOVID THERAPEUTICS INC$19.9M0.91%$2.69$2.83+5.2%
0.9%
ELVNENLIVEN THERAPEUTICS INC$19.7M0.90%$50.75$58.82+15.9%
0.9%
ENTAENANTA PHARMACEUTICALS INC$19.6M0.90%$14.58$13.16-9.7%
0.9%
IWMPUTISHARES TR$18.8M0.86%$300.45$305.09+1.5%
0.9%
SPYPUTSTATE STR SPDR S&P 500 ETF T$18.7M0.85%$746.77$776.34+4.0%
0.8%
NKTRNEKTAR THERAPEUTICS$17.1M0.78%$69.81$73.02+4.6%
0.8%
INSPINSPIRE MED SYS INC$16.7M0.76%$44.61$57.10+28.0%
0.8%
RVMDREVOLUTION MEDICINES INC$16.4M0.75%$187.28$203.71+8.8%
0.8%

Quarter-on-Quarter Activity

Q2 2026 vs. Q1 2026

New Positions (8)

TickerIssuerNotionalSince Filing
EDITEDITAS MEDICINE INC$28.8M-13.0%
VORVOR BIOPHARMA INC$12.5M
SNSEFAETH THERAPEUTICS INC$9.0M
ASNDASCENDIS PHARMA A/S$7.6M
AMANAT ACQUISITION CORP$7.6M
RESEARCH ALLIANCE CORP III$7.0M
RLAYRELAY THERAPEUTICS INC$6.7M
DISCIPLINED GROWTH$5.0M

Exited Positions (8)

TickerIssuerNotional
TERNTERNS PHARMACEUTICALS INC$48.2M
BEAMBEAM THERAPEUTICS INC$34.5M
SRRKSCHOLAR ROCK HLDG CORP$20.0M
TERNTERNS PHARMACEUTICALS INC$10.5M
VRTXVERTEX PHARMACEUTICALS INC$6.7M
VRDNVIRIDIAN THERAPEUTICS INC$6.0M
ASNDASCENDIS PHARMA A/S$5.7M
LLYELI LILLY & CO$4.7M

Increased (8)

TickerIssuerNotionalShares ΔSince Filing
PRAXPRAXIS PRECISION MEDICINES I$24.4M+4850.2%+9.6%
RLYBRALLYBIO CORP$14.6M+4411.1%
ABVXCALLABIVAX SA$235.6M+4001.6%-10.7%
ENTAENANTA PHARMACEUTICALS INC$18.9M+2518.0%-9.7%
IFRXINFLARX NV$6.6M+1795.5%
CRBPCALLCORBUS PHARMACEUTICALS HLDGS$3.6M+1105.1%
FULCFULCRUM THERAPEUTICS INC$4.7M+1098.7%
BHVNBIOHAVEN LTD$7.1M+1020.4%

Trimmed (8)

TickerIssuerNotionalShares ΔSince Filing
ABVXCALLABIVAX SA$-149.3M-96.8%-10.7%
AMLXPUTAMYLYX PHARMACEUTICALS INC$-13.2M-96.0%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$-8.0M-94.1%
MPLTMAPLIGHT THERAPEUTICS INC$-6.7M-92.9%
SNYSANOFI SA$-12.8M-82.0%
CRBPCALLCORBUS PHARMACEUTICALS HLDGS$-2.5M-81.9%
SPYPUTSTATE STR SPDR S&P 500 ETF T$-30.7M-67.1%+4.0%
CBIOCRESCENT BIOPHARMA INC.$-0.6M-63.6%
Back to Hedge Funds